WO2005051316A3 - Compositions a base de polymeres et leurs procedes d'utilisation - Google Patents

Compositions a base de polymeres et leurs procedes d'utilisation Download PDF

Info

Publication number
WO2005051316A3
WO2005051316A3 PCT/US2004/039491 US2004039491W WO2005051316A3 WO 2005051316 A3 WO2005051316 A3 WO 2005051316A3 US 2004039491 W US2004039491 W US 2004039491W WO 2005051316 A3 WO2005051316 A3 WO 2005051316A3
Authority
WO
WIPO (PCT)
Prior art keywords
treatment
methods
polymer compositions
prevention
compositions
Prior art date
Application number
PCT/US2004/039491
Other languages
English (en)
Other versions
WO2005051316A2 (fr
Inventor
William L. Hunter
David M. Gravett
Philip M. Toleikis
Arpita Maiti
Richard T. Liggins
Aniko Takacs-Cox
Rui Avelar
Troy A. E. Loss
Dechi Guan
Original Assignee
Angiotech International Ag
Wang, Kaiyue
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/986,231 external-priority patent/US20050181977A1/en
Application filed by Angiotech International Ag, Wang, Kaiyue filed Critical Angiotech International Ag
Publication of WO2005051316A2 publication Critical patent/WO2005051316A2/fr
Publication of WO2005051316A3 publication Critical patent/WO2005051316A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Communicable Diseases (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Prostheses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)

Abstract

La présente invention a trait à des compositions comportant des agents anti-fibrotiques et/ou des compositions polymériques utilisées dans diverses applications médicales comprenant la prévention d'adhérences chirurgicales, le traitement de l'arthrite inflammatoire, le traitement de cicatrices et de chéloïdes, le traitement de maladie vasculaire, et la prévention de la perte cartilagineuse.
PCT/US2004/039491 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation WO2005051316A2 (fr)

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
US52390803P 2003-11-20 2003-11-20
US60/523,908 2003-11-20
US52522603P 2003-11-24 2003-11-24
US60/525,226 2003-11-24
US52654103P 2003-12-03 2003-12-03
US60/526,541 2003-12-03
US56656904P 2004-04-28 2004-04-28
US60/566,569 2004-04-28
US58686104P 2004-07-09 2004-07-09
US60/586,861 2004-07-09
US61107704P 2004-09-17 2004-09-17
US60/611,077 2004-09-17
US10/986,231 2004-11-10
US10/986,231 US20050181977A1 (en) 2003-11-10 2004-11-10 Medical implants and anti-scarring agents

Publications (2)

Publication Number Publication Date
WO2005051316A2 WO2005051316A2 (fr) 2005-06-09
WO2005051316A3 true WO2005051316A3 (fr) 2010-01-28

Family

ID=34637499

Family Applications (2)

Application Number Title Priority Date Filing Date
PCT/US2004/039389 WO2005051452A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation
PCT/US2004/039491 WO2005051316A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PCT/US2004/039389 WO2005051452A2 (fr) 2003-11-20 2004-11-22 Compositions a base de polymeres et leurs procedes d'utilisation

Country Status (6)

Country Link
EP (1) EP1684819A2 (fr)
JP (1) JP2007517543A (fr)
AU (1) AU2004293071A1 (fr)
CA (1) CA2536181A1 (fr)
IL (1) IL174641A0 (fr)
WO (2) WO2005051452A2 (fr)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003272471B2 (en) 2002-09-18 2010-10-07 Trustees Of The University Of Pennsylvania Method of inhibiting choroidal neovascularization
JP2007516740A (ja) * 2003-11-10 2007-06-28 アンジオテック インターナショナル アーゲー 医療移植片（ｉｍｐｌａｎｔｓ）および瘢痕化抑制剤
BRPI0608152A2 (pt) 2005-02-09 2009-11-10 Macusight Inc formulações para tratamento ocular
US8663639B2 (en) 2005-02-09 2014-03-04 Santen Pharmaceutical Co., Ltd. Formulations for treating ocular diseases and conditions
US20100040666A1 (en) * 2005-06-24 2010-02-18 Hiroshi Azuma Method for Control of Drug Elution Rate and Composition for Coating of Drug-Eluting Stent
JP2007135965A (ja) * 2005-11-21 2007-06-07 Tohoku Univ 体内留置多機能ステントおよびその製造方法
KR20140093764A (ko) 2006-02-09 2014-07-28 산텐 세이야꾸 가부시키가이샤 안정한 제제와 그 제조 및 사용 방법
CN103127100A (zh) 2006-03-23 2013-06-05 参天制药株式会社 用于与血管通透性有关的疾病或病症的制剂和方法
US7846361B2 (en) 2006-07-20 2010-12-07 Orbusneich Medical, Inc. Bioabsorbable polymeric composition for a medical device
US7959942B2 (en) 2006-10-20 2011-06-14 Orbusneich Medical, Inc. Bioabsorbable medical device with coating
US8691321B2 (en) 2006-10-20 2014-04-08 Orbusneich Medical, Inc. Bioabsorbable polymeric composition and medical device background
US9023114B2 (en) 2006-11-06 2015-05-05 Tyrx, Inc. Resorbable pouches for implantable medical devices
EP2079389B1 (fr) * 2006-11-06 2018-01-10 Tyrx, Inc. Poches résorbable pour dispositifs médicaux implantables
US7801624B1 (en) 2007-01-16 2010-09-21 Pacesetter, Inc. Reduced perforation distal tip for an implantable cardiac electrotherapy lead
JP5639764B2 (ja) * 2007-03-08 2014-12-10 シンク−アールエックス，リミティド 運動する器官と共に使用するイメージング及びツール
US11064964B2 (en) 2007-03-08 2021-07-20 Sync-Rx, Ltd Determining a characteristic of a lumen by measuring velocity of a contrast agent
US9375164B2 (en) 2007-03-08 2016-06-28 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
US9629571B2 (en) 2007-03-08 2017-04-25 Sync-Rx, Ltd. Co-use of endoluminal data and extraluminal imaging
WO2009153794A1 (fr) 2008-06-19 2009-12-23 Sync-Rx, Ltd. Avancement progressif d'un instrument médical
US9968256B2 (en) 2007-03-08 2018-05-15 Sync-Rx Ltd. Automatic identification of a tool
US10716528B2 (en) 2007-03-08 2020-07-21 Sync-Rx, Ltd. Automatic display of previously-acquired endoluminal images
US11197651B2 (en) 2007-03-08 2021-12-14 Sync-Rx, Ltd. Identification and presentation of device-to-vessel relative motion
US8542900B2 (en) 2007-03-08 2013-09-24 Sync-Rx Ltd. Automatic reduction of interfering elements from an image stream of a moving organ
WO2009018546A1 (fr) 2007-08-02 2009-02-05 Medicis Pharmaceutical Corporation Procédé d'application d'un produit de comblement des rides injectable
CA2946195A1 (fr) * 2008-07-17 2010-01-21 Micell Technologies, Inc. Dispositif medical d'administration de medicament
US8039433B2 (en) * 2008-08-19 2011-10-18 Warsaw Orthopedic, Inc. Osteogenic compositions containing a coloring agent
US9095313B2 (en) 2008-11-18 2015-08-04 Sync-Rx, Ltd. Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe
US11064903B2 (en) 2008-11-18 2021-07-20 Sync-Rx, Ltd Apparatus and methods for mapping a sequence of images to a roadmap image
US9144394B2 (en) 2008-11-18 2015-09-29 Sync-Rx, Ltd. Apparatus and methods for determining a plurality of local calibration factors for an image
US9974509B2 (en) 2008-11-18 2018-05-22 Sync-Rx Ltd. Image super enhancement
US10362962B2 (en) 2008-11-18 2019-07-30 Synx-Rx, Ltd. Accounting for skipped imaging locations during movement of an endoluminal imaging probe
US8855744B2 (en) 2008-11-18 2014-10-07 Sync-Rx, Ltd. Displaying a device within an endoluminal image stack
US9101286B2 (en) 2008-11-18 2015-08-11 Sync-Rx, Ltd. Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points
HUP1000385A2 (en) 2010-07-21 2012-01-30 Medicontur Orvostechnikai Kft Alkane diol derivatives preparation thereof and based on them
EP2625263B1 (fr) 2010-10-08 2020-03-11 Terumo BCT, Inc. Procédés et systèmes configurables pour la culture et la récolte de cellules dans un système de bioréacteur à fibres creuses
DK2699274T3 (en) 2011-04-20 2015-06-15 Carbylan Therapeutics Inc In situ gelling formations
JP6099640B2 (ja) 2011-06-23 2017-03-22 シンク−アールエックス，リミティド 管腔の背景の鮮明化
ES2666857T3 (es) 2011-07-18 2018-05-08 Mor-Research Applications Ltd. Un dispositivo para ajustar la presión intraocular
CN104010669A (zh) * 2011-10-28 2014-08-27 巴克斯特国际公司 用于骨骼止血的非水性组合物以及它们的使用和制造方法
CA2875346A1 (fr) 2012-06-26 2014-01-03 Sync-Rx, Ltd. Traitement d'image lie au flux dans les organes luminaux
US10179834B2 (en) 2013-04-10 2019-01-15 The University Of Melbourne Biodegradable network polymers for regenerative medicine and tissue engineering
WO2015073918A1 (fr) 2013-11-16 2015-05-21 Terumo Bct, Inc. Expansion de cellules dans un bioréacteur
EP3122866B1 (fr) 2014-03-25 2019-11-20 Terumo BCT, Inc. Remplacement passif de milieu
EP3198006B1 (fr) 2014-09-26 2021-03-24 Terumo BCT, Inc. Alimentation programmée
WO2017004592A1 (fr) 2015-07-02 2017-01-05 Terumo Bct, Inc. Croissance cellulaire à l'aide de stimuli mécaniques
EP3464565A4 (fr) 2016-05-25 2020-01-01 Terumo BCT, Inc. Expansion cellulaire
US11104874B2 (en) 2016-06-07 2021-08-31 Terumo Bct, Inc. Coating a bioreactor
US11685883B2 (en) 2016-06-07 2023-06-27 Terumo Bct, Inc. Methods and systems for coating a cell growth surface
US11624046B2 (en) 2017-03-31 2023-04-11 Terumo Bct, Inc. Cell expansion
EP3656842A1 (fr) 2017-03-31 2020-05-27 Terumo BCT, Inc. Expansion de cellules
EP4368156A2 (fr) 2017-11-09 2024-05-15 ConvaTec Technologies Inc. Système et procédé de surveillance de stomie
WO2020030486A1 (fr) * 2018-08-09 2020-02-13 Gambro Lundia Ab Procédé de détection de l'obstruction d'écoulement dans un circuit extracorporel, appareil et programme informatique
USD893514S1 (en) 2018-11-08 2020-08-18 11 Health And Technologies Limited Display screen or portion thereof with graphical user interface
US20200254103A1 (en) * 2019-02-11 2020-08-13 John Mee Method for treating neurological conditions and improving human cognition
CN113281317B (zh) * 2021-05-14 2022-04-29 北京指真生物科技有限公司 一种含有花菁类化合物的编码微球及其制备方法和应用
CN115382028A (zh) * 2022-09-19 2022-11-25 郑州大学第一附属医院 一种可降解吻合器材料及其制备方法和应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175665A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003520830A (ja) * 2000-01-25 2003-07-08 エドワーズ ライフサイエンシーズ コーポレイション 再狭窄および吻合内膜過形成処置のための送達系
EP1387676A2 (fr) * 2001-05-01 2004-02-11 Angiotech Pharmaceuticals, Inc. Compositions et procedes pour le traitement d'etats inflammatoires par des proteines ou polysaccharides contenant des agents anti-microtubules
US20030207907A1 (en) * 2002-05-03 2003-11-06 Iversen Patrick L. Delivery of microparticle-conjugated drugs for inhibition of stenosis

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050175665A1 (en) * 2003-11-20 2005-08-11 Angiotech International Ag Polymer compositions and methods for their use

Also Published As

Publication number Publication date
CA2536181A1 (fr) 2005-06-09
IL174641A0 (en) 2006-08-20
JP2007517543A (ja) 2007-07-05
AU2004293071A1 (en) 2005-06-09
WO2005051316A2 (fr) 2005-06-09
WO2005051452A2 (fr) 2005-06-09
EP1684819A2 (fr) 2006-08-02

Similar Documents

Publication Publication Date Title
WO2005051316A3 (fr) Compositions a base de polymeres et leurs procedes d'utilisation
WO2006135479A3 (fr) Agents anti-cicatrisation, compositions therapeutiques, et leurs utilisations
WO2007056134A3 (fr) Polymeres phenoliques resorbables
MXPA04001876A (es) Uso de fucanos en el tratamiento de adhesiones, artritis y psoriasis.
EP2497478A3 (fr) Composition d'oligosaccarides et leur utilisation dans le traitement d'infection
WO2007084444A3 (fr) Polymeres cristallisables a chaine laterale pour applications medicales
DE502004007577D1 (en) Lymerpartikel
WO2005016256A3 (fr) Compositions hemostatiques contenant de la thrombine sterile
DK1721623T3 (da) Absorberende polymersammensætninger, medicinske artikler og fremgangsmåder
WO2006074391A3 (fr) Compositions de revetement biodegradables comportant des melanges
EP1699397A4 (fr) Ensembles, systemes et procedes destines a des pansements en tissu formes a partir de structures spongieuses polymeres hydrophiles telles qu'un chitosane
WO2002098477A3 (fr) Modificateurs de surfaces bioactifs destines a des polymeres et a des articles fabriques a partir de polymeres
WO2004108091A3 (fr) Solutions de rinçage antimicrobiennes
DK1315771T3 (da) Bioaktivt materiale
WO2002064189A3 (fr) Hydrogels reticules par rayonnements
HK1094320A1 (en) Antiseptic compositions, methods and systems
WO2009020797A3 (fr) Polymères pour dispositifs implantables à mémoire de forme
GB2430157A (en) Personal care products and methods for inhibiting the adherence of flora to skin
WO2009081408A3 (fr) Caillots de fibrine pulvérisés et compositions pharmaceutiques les contenant
WO2008021548A3 (fr) Poly(ester amides) contenant des époxy et procédés d'utilisation
WO2007038749A3 (fr) Methodes et compositions servant a bloquer l'adherence plaquettaire et cellulaire, la migration cellulaire et l'inflammation
WO2004031129A3 (fr) Nouveaux composes destines au traitement des maladies auto-immunes, des maladies immuno-allergiques et des rejets en cas de greffes d'organes ou de tissus
WO2008153762A3 (fr) Formulations s-nitrosothiol et systèmes d'entreposage
TW200722452A (en) Polymers comprising thioester bonds
AUPQ879500A0 (en) Hyaluronan as cytotoxic agent, drug presensitizer and chemo-sensitizer in the treatment of disease

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200480033522.6

Country of ref document: CN

AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Ref document number: DE

WWE Wipo information: entry into national phase

Ref document number: 1696/KOLNP/2006

Country of ref document: IN

122 Ep: pct application non-entry in european phase